About Motif neurotech
Motif neurotech is a Healthcare company based in Houston (United States) founded in 2022 by Jacob Robinson. Minimally invasive bioelectronics are developed for mental health disorders. Motif neurotech has raised $18.75 million across 1 funding round from investors including Arboretum Ventures, KdT Ventures and Satori Capital. Its chief executive, as recorded, is Jacob Robinson. Motif neurotech offers products and services including DOT. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include Freespira, Neuronetics and Spark Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Motif Neurotech was founded in 2022 in Houston, United States. Operations focus on the bioelectronics sector, where minimally invasive devices are created to address mental health conditions. A miniature brain pacemaker is developed to stimulate neural circuits, aiming to restore healthy brain activity. This approach targets disorders such as treatment-resistant depression, with development centered in the United States.
- Headquarters Houston, United States
- Founders Jacob Robinson
- SectorsHealthcare
- Email••••••••
- Website motifneuro.tech
- Social LinkedIn X YouTube
- Total Equity Funding$18.75M (USD)
in 1 rounds
- Latest Funding Round$18.75M (USD), Series A
Jan 2024
- InvestorsArboretum Ventures
& 10 more
Products & Services of Motif neurotech
Motif neurotech offers a comprehensive portfolio of products and services, including DOT.
Treats depression by activating brain networks in outpatient settings.
Apps and channels of Motif neurotech
its YouTube channel Motif Neurotech has 62 subscribers and 11 videos.
Videos from Motif neurotech
The most watched videos on Motif neurotech's YouTube channel, Motif Neurotech (62 subscribers). Click a video to play it here.
More on Motif Neurotech.
Funding Insights of Motif neurotech
Motif neurotech has successfully raised a total of $18.75M through 1 strategic funding round. The most recent funding activity was a Series A round of $18.75 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.75M
- Total Rounds 1
- Last Round Series A — $18.75M
- First Round $18.75M
(Jan 2024)
- Investors Count 11
All 1 funding rounds of Motif neurotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $18.75M | Series A | – | Arboretum Ventures |
11 investors in total: 10 institutional and 1 angel.
Investors in Motif neurotech
Motif neurotech has secured backing from 11 investors, including venture fund and angel investors. Prominent investors backing the company include Arboretum Ventures, KdT Ventures and Satori Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
Early-stage investments are made in frontier science ventures. | kdtvc.com | Black Mountain, United States | ||
Investment firm specializing in private equity, alternatives, and thematic strategies with a focus on long-term value. | satoricapital.com | |||
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors | dolbyventures.com | San Francisco, United States | ||
Early-stage investments are provided in mental health and brain health sectors. | remind.vc | London, United Kingdom | ||
PsyMed Ventures is focused on funding mental health innovations. | 2022 | psymed.ventures | ||
Investment services are offered by Divergent Capital to companies. | divergenthq.com | |||
| tmc.edu/innovation | ||||
Venture capital investments are made in health and technology sectors. | empath.vc | |||
Acceleration is provided to seed-stage, early-stage, and later-stage companies. | capitalfactory.com | Austin, United States |
Investor details for Motif neurotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Motif neurotech
7 people are tracked at Motif neurotech (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Jacob Robinson | Co-Founder & CEO | Leadership |
Jake Wiederin | Director Of Manufacturing | Leadership |
Nick Halper | Chief Operating Officer | Leadership |
Violet D. | Director Of Executive Operations | Leadership |
Jia Hu | Senior Research And Development Engineer | Team |
Fatima al-Rashdan | Senior Engineer | Team |
Landan Mintch | Product Manager | Team |
Complete people profiles for Motif neurotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Motif neurotech
2 dated milestones of Motif neurotech across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Motif neurotech is founded.
- Funding First funding round of $18.8M.
Competitors of Motif neurotech
Motif neurotech has 3 listed competitors in our database, 3 of them funded. They include Freespira, Neuronetics and Spark Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| freespira.com | 2008 | Danville, United States | $48.94M | 25 | Panic disorders are treated via breathing device and mobile app. | |
| neuronetics.com | 2001 | Malvern, United States | $177.8M | 167 | Non-invasive magnetic therapies for psychiatric and neurological disorders are developed. | |
| sparkbiomedical.com | 2018 | Houston, United States | $31.23M | 18 | Neurostimulation devices for opioid withdrawal symptoms are developed. |
Detailed competitors of Motif neurotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Motif neurotech
The website of Motif neurotech (motifneuro.tech) receives about 5.1K visits a month.
- Monthly visits5.1K
▲ 56.8% vs previous month
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Motif neurotech (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Motif Neurotech
Complete news archive for Motif neurotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Motif neurotech
Motif neurotech was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Motif neurotech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Jacob Robinson is the CEO of Motif neurotech, as recorded in our data. They have also founded this company.
Motif neurotech is a funded company, having raised a total of $18.75M across 1 funding round to date. The company's 1st funding round was a Series A of $18.75M, raised on Jan 2024.
Motif Neurotech was founded in 2022 in Houston, United States. Operations focus on the bioelectronics sector, where minimally invasive devices are created to address mental health conditions. A miniature brain pacemaker is developed to stimulate neural circuits, aiming to restore healthy brain activity. This approach targets disorders such as treatment-resistant depression, with development centered in the United States.
Motif neurotech's top competitors include Spark Biomedical, Neuronetics and Freespira.
Motif neurotech offers DOT.
Motif neurotech has 11 investors. Key investors include Arboretum Ventures, KdT Ventures, Satori Capital, Dolby Family Ventures, and re.Mind Capital.